BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27815226)

  • 1. Utility of the serum galactomannan assay for the diagnosis of invasive aspergillosis in children with acute lymphoblastic leukemia.
    Avcu G; Karapinar DY; Akinci AB; Sivis ZO; Sahin A; Bal ZS; Polat SH; Metin DY; Vardar F; Aydinok Y
    Int J Infect Dis; 2017 Jan; 54():8-12. PubMed ID: 27815226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Threshold of galactomannan antigenemia positivity for early diagnosis of invasive aspergillosis in neutropenic children.
    Dinand V; Anjan M; Oberoi JK; Khanna S; Yadav SP; Wattal C; Sachdeva A
    J Microbiol Immunol Infect; 2016 Feb; 49(1):66-73. PubMed ID: 24582464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Biomarker Screening for Diagnosis of Invasive Aspergillosis in High-Risk Pediatric Patients.
    Loeffler J; Hafner J; Mengoli C; Wirth C; Heussel CP; Löffler C; White PL; Ullmann AJ; Michel D; Wiegering V; Wölfl M; Schlegel PG; Einsele H; Springer J; Eyrich M
    J Clin Microbiol; 2017 Jan; 55(1):101-109. PubMed ID: 27795339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Utility of Galactomannan Enzyme Immunoassay in Invasive Aspergillosis in Pediatric patients with Hematological Malignancy.
    Das S; Capoor MR; Singh A; Agarwal Y
    Mycopathologia; 2023 Dec; 188(6):1055-1063. PubMed ID: 37806994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of serum galactomannan assay in the diagnosis of pediatric invasive pulmonary aspergillosis].
    Zhang XY; Zhao SY; Jiang ZF
    Zhonghua Er Ke Za Zhi; 2009 Feb; 47(2):83-6. PubMed ID: 19573449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum galactomannan assay for the diagnosis of invasive aspergillosis in children with haematological malignancies.
    Jha AK; Bansal D; Chakrabarti A; Shivaprakash MR; Trehan A; Marwaha RK
    Mycoses; 2013 Jul; 56(4):442-8. PubMed ID: 23369047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum galactomannan for diagnosing invasive aspergillosis in pediatric patients: A meta-analysis.
    Tong T; Shen J; Xu Y
    Microb Pathog; 2018 May; 118():347-356. PubMed ID: 29614368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.
    Hadrich I; Makni F; Cheikhrouhou F; Neji S; Amouri I; Sellami H; Trabelsi H; Bellaaj H; Elloumi M; Ayadi A
    Pathol Biol (Paris); 2012 Dec; 60(6):357-61. PubMed ID: 22154334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of the Aspergillus galactomannan antigen testing for neutropenic paediatric patients.
    Sav H; Atalay MA; Koc AN; Unal E; Demir G; Zararsiz G
    Infez Med; 2017 Mar; 25(1):38-44. PubMed ID: 28353454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patients.
    Couchepin J; Brunel AS; Jaton K; Meylan P; Bochud PY; Lamoth F
    Mycoses; 2018 Jun; 61(6):350-354. PubMed ID: 29453853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Galactomannan Antigen and Aspergillus DNA Real-time Polymerase Chain Reaction as Routine Methods for Invasive Aspergillosis in Immunosuppressed Children in Greece.
    Vrioni G; Theodoridou K; Tsiamis C; Mavrouli M; Kapsimali V; Rigopoulos D; Tsakris A
    Clin Ther; 2018 Jun; 40(6):918-924.e2. PubMed ID: 29807668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum galactomannan levels in the diagnosis of invasive aspergillosis.
    Okuturlar Y; Ozkalemkas F; Ener B; Serin SO; Kazak E; Ozcelik T; Ozkocaman V; Ozkan HA; Akalin H; Gunaldi M; Ali R
    Korean J Intern Med; 2015 Nov; 30(6):899-905. PubMed ID: 26552466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
    Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
    Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis.
    Maertens J; Verhaegen J; Demuynck H; Brock P; Verhoef G; Vandenberghe P; Van Eldere J; Verbist L; Boogaerts M
    J Clin Microbiol; 1999 Oct; 37(10):3223-8. PubMed ID: 10488181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis.
    Hidalgo A; Parody R; Martino R; Sánchez F; Franquet T; Giménez A; Blancas C
    Eur J Radiol; 2009 Jul; 71(1):55-60. PubMed ID: 18468830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of bronchoalveolar lavage galactomannan in the diagnosis of pediatric invasive aspergillosis.
    Desai R; Ross LA; Hoffman JA
    Pediatr Infect Dis J; 2009 Apr; 28(4):283-6. PubMed ID: 19238113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies.
    Weisser M; Rausch C; Droll A; Simcock M; Sendi P; Steffen I; Buitrago C; Sonnet S; Gratwohl A; Passweg J; Fluckiger U
    Clin Infect Dis; 2005 Oct; 41(8):1143-9. PubMed ID: 16163633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of serum galactomannan in mixed ICU patients: a retrospective observational study.
    Teering S; Verreth A; Peeters A; Van Regenmortel N; De Laet I; Schoonheydt K; Dits H; Van De Vyvere M; Libeer C; Meersseman W; Malbrain ML
    Anaesthesiol Intensive Ther; 2014; 46(3):145-54. PubMed ID: 25078766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variables affecting the performance of galactomannan assay in high-risk patients at a tertiary care centre in India.
    Khanna S; Oberoi JK; Datta S; Aggarwal S; Wattal C
    Indian J Med Microbiol; 2013; 31(1):34-9. PubMed ID: 23508427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.